Squarepoint’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26M Buy
1,103,490
+647,614
+142% +$16.5M 0.06% 573
2025
Q4
$13.2M Buy
455,876
+296,029
+185% +$7.58M 0.03% 950
2025
Q3
$3.01M Sell
159,847
-7,967
-5% -$126K 0.01% 1778
2025
Q2
$2.35M Buy
167,814
+105,487
+169% +$1.48M 0.01% 1984
2025
Q1
$975K Sell
62,327
-59,065
-49% -$832K ﹤0.01% 2688
2024
Q4
$1.69M Buy
121,392
+48,769
+67% +$534K ﹤0.01% 2566
2024
Q3
$675K Buy
+72,623
New +$717K ﹤0.01% 2898
2024
Q2
Sell
-205,870
Closed -$2.04M 4038
2024
Q1
$2.04M Buy
205,870
+56,447
+38% +$421K 0.01% 2061
2023
Q4
$483K Buy
149,423
+90,565
+154% +$246K ﹤0.01% 3027
2023
Q3
$313K Buy
+58,858
New +$501K ﹤0.01% 3135
2023
Q1
Sell
-36,227
Closed -$536K 3208
2022
Q4
$536K Buy
36,227
+20,946
+137% +$366K ﹤0.01% 2239
2022
Q3
$292K Buy
+15,281
New +$346K ﹤0.01% 2499
2021
Q2
Sell
-10,649
Closed -$308K 3208
2021
Q1
$308K Sell
10,649
-38,433
-78% -$1.2M ﹤0.01% 2372
2020
Q4
$1.38M Buy
+49,082
New +$1.2M 0.01% 1142
2020
Q3
Sell
-12,422
Closed -$376K 2476
2020
Q2
$376K Buy
+12,422
New +$359K 0.01% 1468

Other funds holding ARQT